Publizierte wissenschaftliche Arbeiten

2017

Schnedl WJ, Lackner S, Enko D, Schenk M, Mangge H, Holasek SJ. Non-celiac gluten sensitivity. People without celiac disease avoiding gluten – Is it due to histamine intolerance? Inflamm Res 2017, in press

Schnedl WJ, Schenk M, Lackner S, Holasek SJ, Mangge H. β-thalassemia minor, carbohydrate malabsorption and histamine intolerance. J Comm Hosp Int Med Persp 2017, 7:227-229.

Enko D, Wagner H, Kriegshäuser G, Brandmayr W, Halwachs-Baumann G, Schnedl WJ, Zelzer S, Mangge H, Meinitzer A. Assessment of tryptophan metabolism and signs of depression in individuals with carbohydrate malabsorption. Psychiatry Res 2017, S0165-1781(17)30933-2.

Schnedl WJ. Gleichzeitige Prävalenz von niedriger Serum-Diaminoxidase-Aktivität und Kohlenhydrat- Malabsorption. Gastro & Hepa News 2017, 10: 13-15.

Schnedl WJ, Enko D, Mangge H, Schenk M, Lackner S, Holasek SJ. Bening pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption. Proc (Bayl Univ Med Cent) 2017, 30: 177-78.

Schnedl WJ, Enko D, Wallner-Liebmann SJ, Lackner S, Mangge H. Dissimilar pain of primary epiploic appendagitis and malabsorption. J Clin Diagn Res 2017, 11: OD14-OD15

Enko D, Kriegshäuser G, Halwachs-Baumann G, Mangge H, Schnedl WJ. Serum diamine oxidase activity is associated with lactose malabsorption phenotypic variation. Clin Biochem 2017, 50: 50-53

2016

Enko D, Meinitzer A, Mangge H, Kriegshäuser G, Halwachs-Baumann G, Reininghaus EZ, Bengesser SA, Schnedl WJ. Concomitant prevalence of low serum diamine oxidase activity and carbohydrate malabsorption. Can J Gastroenterol Hepatol 2016; 2016: 4893501

Zelzer S, PrĂĽller F, Schnedl WJ, Weghuber D, Enko D, Bergsten P, Haybaeck J, Meinitzer A. Branched chain amino acids indicate cardio metabolic risk independent of body mass index. J Nutr Biochem 2016; 32: 123-127

Kaimbacher PS, Wallner-Liebmann SJ, Dunitz-Scheer M, Scheer PJ, Cvirn G, Schrabmair  W, Greilberger J, Schnedl WJ, Tafeit E. Significant decrease of subcutaneous body fat during tube-weaning from enteral feeding. Minerva Pediatr 2016, 68: 50-60

Schnedl WJ, Kalmar P, Wallner-Liebmann SJ, Reiter G, Mangge H, Lipp RW. Anomaly of the inferior vena cava and lactose malabsorption. Phlebologie 2016, 45: 35-39

Schnedl W. Histaminintoleranz. Arzt + Patient 2016, 1: 30-32

2015

Kaimbacher PS, Wallner-Liebmann SJ, Dunitz-Scheer M, Scheer PJZ, Cvirn G, Schrabmair W, Schnedl WJ, Hamlin MJ, Tafeit E. Subcutaneous adipose tissue topography in long-term enterally fed children and healthy controls. Coll Antropol 2015, 39: 601-609 

Mangge H, Baumgartner B, Schnedl W. Letter: PNPLA3, metabolic syndrome and NAFLD status in obese subjects – authors‘ reply. Aliment Pharmacol Therap 2015, 42: 630-1

Mangge H, Baumgartner BG, Zelzer S, Prüller F, Schnedl WJ, Reininghaus EZ, Haybäck J, Lackner C, Stauber R, Aigner E, Weghuber D. Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese juveniles and metabolic syndrome in all ages. Aliment Pharmacol Therap 2015, 42: 99-105

Schnedl WJ, Kalmar P, Mangge H, Krause R, Wallner-Liebmann SJ. Co-occurrence of carbohydrate malabsorption and primary epiploic appendagitis. World J Gastroenterol 2015, 21: 10242-54

Schnedl W. Histaminintoleranz. Arzt & Praxis 2015, 69: 75-77

Mangge H, Zelzer S, Meinitzer A, Stelzer I, Schnedl WJ, Weghuber D, Fuchs D, Postolache TT, Aigner E, Datz C, Reininghaus EZ. 25OH-vitamin D3 levels in obesity and metabolic syndrome-unaltered in young and not correlated to carotid IMT in all ages. Curr Pharm Des 2015: 21: 2243-9

2014

Schnedl WJ, Lipp RW, Wallner-Liebmann S, Kalmar P, Szolar DH, Mangge H. Primary epiploic appendagitis and fructose intolerance. Europ J Clin Nutr 2014, 68: 1359-61

Schnedl W. Diabetes mellitus Typ 1. Arzt & Praxis 2014, 68: 149-152

Mangge H, Weghuber D, Prassl R, Haara A, Schnedl W, Postolache TT, Fuchs D. The role of vitamin D in atherosclerosis inflammation revisited: More a bystander than a player? Curr Vasc Pharmacol 2014, 13: 392-8

2013

Kruschitz R, Wallner-Liebmann SJ, Hamlin MJ, Moser M, Ludvik B, Schnedl WJ, Tafeit E. Detecting body fat – a weighty problem BMI versus subcutaneous fat patterns in athletes and non-athletes. PLoS One 2013, 26;8: e72002

Wallner-Liebmann SJ, Kruschitz R, HĂĽbler K, Hamlin MJ, Schnedl WJ, Moser M, Tafeit E. A measure of obesity: BMI versus subcutaneous fat patterns in young athletes and nonathletes. Coll Antropol 2013, 37: 351-357

Mangge H, Schnedl WJ, Schröcksnadel S, Geisler S, Murr C, Fuchs D. Immune activation and inflammation in patients with cardiovascular disease are associated with elevated phenylalanine-to-tyrosine ratios. Pteridines 2013, 24: 51-55

Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R, Schnedl WJ, Reininghaus E, Paulmichl K, Weghuber D, Fuchs D. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity 2013, 22: 195-201

Weghuber D, Zelzer S, Stelzer I, Paulmichl K, Kammerhofer D, Schnedl W, Molnar D, Mangge H. High risk vs. „metabolically healthy“ phenotype in juvenile obesity – neck subcutaneous adipose tissue and serum uric acid are clinically relevant. Exp Clin Endocrinol Diabetes 2013, 121: 384-390

Mangge H, Summers K, Almer G, Prassl R, Weghuber D, Schnedl W, Fuchs D. Antioxidant food supplements and obesity-related inflammation. Curr Med Chem 2013 , 20: 2330-2337

Schnedl WJ, Mirzaei S, Wallner-Liebmann S, Tafeit E, Mangge H, Krause R, Lipp RW. Improvement of cerebral hypoperfusion with levothyroxine therapy in Hashimoto`s encephalopathy demonstrated by 99mTc-HMPAO-SPECT. Europ Thyroid J 2013, 2: 116-119

Schnedl W. 100 Jahre Hashimoto Thyreoiditis (chronische SchilddrĂĽsenentzĂĽndung). Arzt & Praxis 2013, 67: 12-14

Wallner-Liebmann S, Moeller R, Horejsi R, Jürimäe T, Jürimäe J, Mästu J, Purge P, Saar M, Tafeit E, Kaimbacher P, Kruschitz R, Weghuber D, Schnedl WJ, Mangge H. Normal weight Estonian prepubertal boys show a more cardiovascular-risk-associated adipose tissue distribution than Austrian counterparts. ISNR Obesity 2013, : 506751

Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT, Weghuber D. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity 2013, 21: E71-77

2012

Theiler G, Langer-Wegscheider B, Zollner-Schwetz I, Valentin T, Hönigl M, Schnedl W, Krause R. Blurred vision and myopic shift in Puumala virus infections are independent of disease severity. Clin Microbiol Infect 2012, 18: E435-437

Schnedl WJ, Krause R, Wallner-Liebmann SJ, Tafeit E, Mangge H, Tillich M. Primary epiploic appendagitis and successful outpatient management. Med Sci Monit 2012, 18: CS48-51

Stelzer I, Zelzer S, Raggam RB, Prüller F, Truschnig-Wilders M, Meinitzer A, Schnedl WJ, Horejsi R, Möller R, Weghuber D, Reeves G, Postolache TT, Mangge H. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 2012, 159: 118-124

Prüller F, Raggam R, Posch V, Almer G, Truschnig-Wilders M, Horejsi R, Möller R, Weghuber D, Ille R, Schnedl W, Mangge H. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis 2012, 220: 215-218

2011

Zelzer S, Fuchs N, Almer G, Raggam RB, Prüller F, Truschnig-Wilders M, Schnedl W, Horejsi R, Möller R, Weghuber D, Ille R, Mangge H. High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers. Clin Chim Acta 2011, 412: 1345-1349

Mangge H, Almer G, Zelzer S, Vasan R, Kraigher-Krainer E, Gasser R, Schnedl W, Ille R, Wallner S, Möller R, Horejsi R, Weghuber D. N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. Clin Chem Lab Med 2011, 49: 1539-46

Schnedl W: Diabetes mellitus und Osteoporose. Arzt & Praxis 2011, 65: 330-33

Kaimbacher PS, Dunitz-Scheer M, Wallner-Liebmann SJ, Scheer PJZ, Sudi K, Schnedl WJ, Tafeit E. Decrease of total subcutaneous adipose tissue from infancy to childhood. J Ped Gastoenterol Nutr 2011, 53: 553-560

Schnedl WJ, Krause R, Tafeit E, Tillich M, Lipp RW, Wallner-Liebmann SJ: Insights into epiploic appendagitis. Nat Rev Gastroenterol Hepatol 2011, 8: 45-49

Hoenigl M, Zollner-Schwetz I, Sill H, Linkesch W, Lass-Flörl C, Schnedl WJ, Krause R: Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haemotological malignancies. Mycoses 2011, 54: 454-459

2010

Schnedl WJ: Vitamin D und Diabetes mellitus. Arzt & Praxis 2010, 64: 228-229

Schnedl WJ, Tillich M, Lipp RW: Image of the month. Primary epiploic appendagitis. Clin Gastroenterol Hepatol 2010 ,8: A16

Schnedl WJ, Reittner P, Krause R, Lipp RW, Tafeit E, Wallner-Liebmann S: Patent abdominal subcutaneous veins caused by congenital absence of the inferior vena cava. J Med Case Rep 2010, 4: 223

2009

Tafeit E, Greiberger J, Cvirn G, Lipp RW, Schnedl WJ, Jurimae J, Wallner-Liebmann SJ. Estimating DXA total body fat percentage by Lipometer subcutaneous adipose tissue thiknesses. Collegicum Antropol 2009, 33: 391-396

Schnedl WJ, Krause R, Tafeit E, Wallner SJ: Autoimmune hepatitis and motor axonal neuropathy. Digestion 2009, 80: 50-51

Schnedl WJ, Piswanger-Soelkner C, Wallner SJ, Krause R, Lipp RW: Agenesis of the dorsal pancreas. Diabet Med 2009, 26: 110 – 114

Schnedl WJ, Piswanger-Sölkner C, Wallner SJ, Reittner P, Krause R, Lipp RW, Hohmeier HE: Agenesis of the dorsal pancreas and associated diseases. Dig Dis Sci 2009, 54: 481-487

Schnedl WJ: Das glykierte Hämoglobin (A1C) zur Diagnose bei Diabetes mellitus. Arzt & Praxis 2009, 63 (995a): 4-6

Schnedl WJ, Piswanger-Soelkner C, Wallner SJ, Krause R, Lipp RW: Agenesis of the dorsal pancreas. World J Gastroenterol 2009, 15 : 376 – 379

2008

Tafeit E, Horejsi R, Pieber TR, Roller RE, Schnedl WJ, Wallner SJ, Jurimae T, Moller R: Subcutaneous fat patterns in type-2 diabetic men and healthy controls. Collegicum Antropol 2008, 32: 607-614

Wallner SJ, Horejsi R, Zweicker R, Watzinger N, Möller R, Schnedl WJ, Schauenstein K, Tafeit E: ROC analysis of subcutaneous adipose tissue topography (SAT-Top) in female coronary heart disease patients and healthy controls. J Physiol Anthropol 2008, 27: 185-191

Schnedl WJ, Krause R, Wallner SJ, Piswanger-Soelkner C, Lipp RW: Effect of silent hemoglobin variants on A1C measurement with the IFCC reference method and 6 routine methods. Clin Chim Acta 2008, 398: 161-162

Piswanger-Sölkner C, Schnedl W: Sekundäre Osteoporose: Diagnose und Therapie. Top-Medizin 2008, 17: 6-8

Piswanger-Sölkner C, Schnedl W: Sekundäre Osteoporose: Diagnose und Therapie. Urologik 2008,15: 42- 43

Wallner SJ, Lothaller H, Liebmann PM, Schnedl WJ, Wascher TC: Evaluation of weight-management programms and body-composition: impact of the return ratio of questioning. J Biophys Biomed Sci 2008, 1: 20-24

2007

Schnedl WJ, Lahousen T, Krause R, Wallner SJ, Piswanger-Sölkner C, Lipp RW: Evaluation of conditions associated with glycated hemoglobin values below the reference range. Clin Lab 2007, 53: 179-181

Jurimäe T, Jurimäe J, Wallner SJ, Lipp RW, Schnedl WJ, Möller R, Tafeit E: Relationships between body fat measured by DXA and subcutaneous adipose tissue thickness measured by Lipometer in adults. J Physiol Anthropol 2007, 26:513-516

Schnedl W: Hashimoto-Thyreoiditis (Autoimmunthyreoiditis). Der Mediziner 2007, 1/2: 20-21

Schnedl W: NAFLE und NASH – In westlichen Ländern die häufigsten Lebererkrankungen. JATROS Diabetes & Stoffwechsel 2007, 1: 48-49

Schnedl W: Antihypertensive Therapie des Diabetes mellitus. Arzt & Praxis 2007, 61: 372-373

2006

Hoier S, Aberle SW, Langner C, Schnedl W, Högenauer C, Reisinger EC, Krejs GJ, Krause R: Puumala Virus RNA in Patient with Multiorgan Failure. Emerg Infect Dis 2006, 12: 356-357

Krause R, Piswanger-Sölkner C, Lipp RW, Daxböck F, Schnedl WJ, Hoier S, Reisinger EC: Somatostatin receptor scintigraphy in patients with cat-scratch disease. Nuklearmedizin 2006, 45: 160-162

Schnedl W: NAFLE und NASH – Die häufigsten Leberschäden in westlichen Ländern. Top-Medizin 2006, 4: 10-11

2005

Schnedl WJ, Lahousen T, Wallner SJ, Krause R, Lipp RW: Silent hemoglobin variants and determination of HbA1c with the high resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem 2005, 38: 88-91

Schnedl WJ, Pilhatsch A, Szolar DH, Krause R, Wallner SJ, Piswanger C, Lipp RW: Intestinal malrotation and delayed gastric emptying. Nuklearmedizin 2005, 44: N46-48

Schnedl WJ, Wallner SJ, Piswanger C, Krause R, Lipp RW: Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med Wochenschr 2005, 155: 411-415

Piswanger C, Schnedl W: Hypothyreose – Hormone frühzeitig substituieren. Top-Medizin 2005, 15: 26-28

ältere Publikationen

Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ: Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004, 10: 2284-2286

Wallner SJ, Luschnigg N, Schnedl WJ, Lahousen T, Sudi K, Crailsheim K, Moller R, Tafeit E, Horeijsi R: Body fat distribution of overweight females with a history of weight cycling. Int J Obes Relat Metab Disord 2004, 28: 1143-1148

Schnedl WJ, Lahousen T, Lang T, Lipp RW, Yonehara S, Fukunaga S, Imai T, Little RR: Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev 2004, 20: 460-465

Schnedl W: Insulinanaloga – Optimierung der Diabetestherapie. Arzt & Praxis 2004, 58:400-403

Schnedl W: Lebererkrankungen bei Diabetes mellitus. Arzt & Praxis 2004, 59:272-273

Lahousen T, Lipp RW, Schnedl WJ: Can hyperglycaemia cause jejuno-jejunal intussusception? Diabet Med 2003, 20:335-336

Schnedl WJ, Lipp RW: Can human pancreatic b-cells regenerate in vivo? Diabetes Res Clin Pract 2003, 61:77-79

Lahousen T, Schnedl WJ: Inselzelltransplantation und gentechnisch modifizierte insulinproduzierende Zellen zur Therapie bei Diabetes mellitus. Intern Praxis 2003, 43:59-64

Schnedl W: Das sollten Sie über glykiertes Hämoglobin wissen. Arzt & Praxis 2003, 57:82-85

Schnedl W: Metformin – ein Update. Arzt & Praxis 2003, 57: 328-330

Lahousen T, Schnedl WJ: Inselzelltransplantation und gentechnisch modifizierte insulin-produzierende Zellen zur Therapie bei Diabetes mellitus. Tägliche Praxis 2003, 44:521-527

Obernosterer A, Aschauer M, Schnedl W, Lipp RW: Anomalies of the inferior vena cava in patients with iliac vein thrombosis. Ann Intern Med 2002, 136:37-41

Krause R, Ramschak-Schwarzer S, Gorkiewicz G, Schnedl WJ, Feierl G, Wenisch C, Reisinger EC: Recurrent septicemia due to Campylobacter fetus and Campylobacter lari in an immunocompetent patient. Infection 2002, 30:171-174

Lahousen T, Roller RE, Lipp RW, Schnedl WJ: Silent hemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II. J Clin Pathol 2002, 55:699-703

Stingl H, Schnedl WJ, Krssak M, Bernroider E, Bischof MG, Lahousen T, Pacini G, Roden M: Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas. J Clin Endocrinol Metabol 2002, 87:4678-4685

Obernosterer A, Aschauer M, Schnedl W, Lipp RW: Summaries for patients. Blood clots and abnormal vessels of the inferior vena cava. Ann Intern Med 2002, 136:S-69

Lahousen T, Roller RE, Lipp RW, Schnedl WJ: Über die Bestimmung des glykierten Hämoglobins (HbA1c). Wien Klin Wochenschr 2002, 114:301-305

Roller RE, Renner W, Dorr A, Pilger E, Schnedl WJ: Oxidative stress and increase in vascular endothelial growth factor in patients with peripheral arterial occlusive disease. Thromb Haemost 2001, 85:368

Roller RE, Renner W, Tischler R, Pilger E, Schnedl WJ: Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty. Thromb Haemost 2001, 85:1119-1120

Roller RE, Nimmrichter V, Trinker M, Seinost G, Schnedl WJ, Pilger E: Oxidative stress during peripheral angioplasty – Implication for late restenosis? Int Angiology 2001; 20:131-135

Roller RE, Lahousen T, Lipp RW, Korninger C, Schnedl WJ: Elevated D-dimer results in a healthy patient. Blood Coagul Fibrin 2001, 12:501-502

Schnedl WJ, Liebminger A, Roller ER, Lipp RW, Krejs GJ: Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev 2001, 17:94-98

Schnedl W: Neue Erkenntnisse der Ă„tiologie des Diabetes mellitus Typ 2. Arzt & Praxis 2001, 55:290-293

Roller RE, Schnedl WJ, Korninger C: Predicting the risk of restenosis after angioplasty in patients with peripheral arterial disease. Clin Lab 2001, 47:555-559

Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ: Evaluation of hemoglobin A1c determination methods in patients with hemoglobin variants. Diabetes Care 2000, 23:339-344

Lipp RW, Schnedl WJ, Hammer HF, Kotanko P, Leb G, Krejs GJ: Effects of postprandial walking on delayed gastric emptying and intragastric meal distribution in longstanding diabetics. Am J Gastroenterol 2000, 23:419-424

Roller ER, Obernosterer A, Dorr A, Schnedl WJ: No association of TGF-b1 antigen with the development of restenosis in patients undergoing peripheral angioplasty. Thromb Haemost 2000, 84:518-519

Roller ER, Janisch S, Kvas E, Schnedl WJ, Binder BR, Wojta J, Korninger C: Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty. Thromb Haemost 2000, 84:1113-1116

Lipp RW, Schnedl WJ, Stauber R, Ranner G, Leb G, Krejs GJ: Scintigraphic long-term follow-up of a patient with metastatic glucagonoma. Am J Gastroenterol 2000, 23:1818-1820

Lipp RW, Schnedl WJ: Procedure guideline for gastric emptying and motility. J Nucl Med 2000, 41:1443

Schnedl WJ, Stepan VE, Roller RE, Lipp RW: HbA1c determination with high performance liquid chromatography. Diabetes Care 2000, 23:874-875

Schnedl WJ, Liebminger A, Roller RE, Lipp RW: HbA1c determination and predicting the clinical status of diabetic patients. Diabetes Care 2000, 23:1597

Schnedl W: Glykiertes Hämoglobin (HbA1c). Forum Dr Med 2000, 13:6-7

Schnedl W: Neue gentechnisch hergestellte Insulinanaloga. Forum Dr Med 2000, 18:20-24

Schnedl W: Moderne Therapiestrategien bei Diabetes mellitus Typ 2. Forum Dr Med 2000, 4:18-20

Schnedl WJ, Trinker M, Lipp RW: Hemoglobin A1c-determination in patients with hemoglobin variants. Diabetes Care 1999, 22:368-369

Schnedl WJ, Wenzl HE, Obermayer-Pietsch B, Roller ER, Lipp RW: Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care 1999, 22:1920-1921

Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H: Visualization of non-Hodgin’s lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography. Acta Med Austr 1999, 26:105-108

Schnedl WJ, Lipp RW, Trinker M, Ranner G, Schreiber F, Krejs GJ: Scintigraphy and magnetic resonance imaging in adult onset Still’s disease. Scand J Rheumatol 1999, 28:257-259

Roller RE, Trinker M, Schnedl WJ, Pilger E, Korninger C: Lack of association between elevated serum Lp(a) and local thrombus lysability in patients with peripheral arterial occlusive disease. Blood Coagul Fibrin 1999, 10:449-450

Schnedl WJ: Die Entwicklung von Insulinomzellen zur Therapie bei insulin-pflichtigem Diabetes mellitus. Wien Klin Wochenschr 1999, 111:428-433

Schnedl WJ, Lipp RW, Trinker M, Hopmeier P: Hemoglobin D [b 121(GH4)Glu-Gln] causing falsely low and high HbA1c-values in high performance liquid chromatography. Clin Chem 1998, 44:1999-2000

Schnedl WJ, Reisinger EC, Katzensteiner S, Lipp RW, Schreiber F, Hopmeier P, Krejs GJ: Haemoglobin O Padova causes falsely low haemoglobin A1c values in a type I diabetic patient. J Clin Pathol 1997, 50:434-435

Lipp RW, Schnedl WJ: Is rapid gastric emptying in type II diabetics emptying the stomach in less time than in normal subjects? Diabetes Care 1997, 20:116

Lipp RW, Schnedl WJ, Ranner G, Hammer HF, Kotanko P, Leb G, Krejs GJ: Evidence of accelerated gastric emptying in long-standing diabetic after ingestion of a semisolid meal. J Nucl Med 1997, 38:814-818

Halwachs-Baumann G, Katzensteiner S, Schnedl W, PĂĽrstner P, Pieber T, Wilders-Truschnig M: Comparative evaluation of three assay systems for the automated determination of hemoglobin A1c. Clin Chem 1997, 43:511-517

Schnedl WJ, Lipp RW, Reisinger EC: Rheumatic pain in female diabetic patients. Scand J Rheumatol 1997, 26:135-137

Schnedl WJ: Hämoglobin Graz eine neue Hämoglobinvariante in Österreich. Der Mediziner 1997, 2:43-44

Schnedl WJ, Leitner G, Lipp RW: Glykiertes Hämoglobin und glykierte Proteine zur Stoffwechselkontrolle bei Diabetes mellitus. Wien Med Wochenschr 1997, 147:359-361

Schreiber F, Gurakuqi GCH, Pristautz H, Trauner M, Schnedl W: Sonographically-guided extracorporeal shockwave lithotripsy for pancreatic stones in patients with chronic pancreatitis. J Gastroenterol Hepatol 1996, 11:247-251

Schnedl WJ, Hohmeier H, Newgard CB: Insulin-sezernierende Zellen zur Therapie des Diabetes mellitus. Naturwissenschaften 1996, 83:1-5

Schnedl WJ, Reisinger EC: Bestimmung von glykiertem Hämoglobin bei Hämoglobinvarianten. Wien Klin Wochenschr 1996, 108:44

Schnedl WJ, Reisinger EC, Lipp RW, Uggowitzer, Mischinger HJ, Fickert P, Krejs GJ: Biliary obstruction due to duodenojejunal intussusception in Peutz Jeghers syndrome. J Clin Gastroenterol 1996, 23:220-223

Schreiber F, Gurakuqi GCH, Schnedl W, Trauner M: ERCP and ballon dilatation is a valuable alternative to surgical biliodigestive anastomosis in the Long Common Channel syndrome in childhood. Endoscopy 1996, 28:724

Lipp RW, Schnedl WJ, Hammer HF: Does postprandial walking influence delayed gastric emptying in patients with long-standing IDDM? Diabetes Care 1996, 19:1306

Reisinger EC, Schnedl WJ, Krejs GJ: Malodorous wounds. Lancet 1996, 348:1736-1737

Schreiber F, Steindorfer P, Pristautz H, Gurakuqi GC, Schnedl W, Trauner M: Complications and surgical interventions during 4 years of biliary extracorporeal shockwave lithotripsy. Hepato Gastroenterol 1996, 43:1124-1128

Schnedl WJ, Reisinger EC, Pieber TR, Neubauer M, Balaun E, Krejs GJ, Hopmeier P: Haemoglobin Graz a novel haemoglobin variant. Diabetologia 1995, 38:122

Schnedl WJ, Reisinger EC, Pieber TR, Lipp RW, Schreiber F, Hopmeier P, Krejs GJ: Hemoglobin Sherwood Forest detected by high performance liquid chromatography. Am J Clin Pathol 1995, 104:444-446

Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ: Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 1995, 18:625-630

Schnedl WJ, Reisinger EC, Lipp RW, Krejs GJ, Hopmeier P: Hemoglobin variants recently detected in Austria. Ann Hematol 1995, 71:185-187

Schnedl WJ, Reisinger EC, Schreiber F, Pieber TR, Lipp RW, Krejs GJ: Complete and partial agenesis of the dorsal pancreas within one family. Gastrointest Endosc 1995, 42:485-487

Pieber TR, Holler A, Brunner GA, Schattenberg S, Schnedl WJ, Semlitsch B, Zapotoczky H, Krejs GJ: Diabetesbetreuung in Österreich 5 Jahre nach der St. Vincent-Erklärung. Wien Klin Wochenschr 1995, 107:451-456

Schnedl WJ, Ferber S, Johnson JH, Newgard CB: Streptozotocin transport and cytotoxicity: specific enhancement in GLUT-2 expressing cell lines. Diabetes 1994, 43:1326-1333

Ferber S, Schnedl WJ, BeltrandelRio H, Irminger JC, Halban P, Newgard CB: Molecular strategies for treatment of diabetes. Transpl Proc 1994, 26:363-365

BeltrandelRio H, Schnedl WJ, Ferber S, Newgard CB: Genetic engineering of insulin secreting cell lines. In: Chick WL, Lanza RP, eds. (Landes, Austin) Pancreatic islet transplantation, 1994, 169-183 (ISBN 1-57059-133-4)

Wildling R, Schnedl WJ, Reisinger EC, Schreiber F, Lipp RW, Lederer A, Krejs GJ: Agenesis of the dorsal pancreas in a woman with diabetes mellitus and both of her sons. Gastroenterology 1993, 104:1182-1186

Lipp RW, Hammer HF, Schnedl WJ, Dobnig H, Passath A, Leb G, Krejs GJ: A simple scintigraphic method for continuous monitoring of gastric emptying. Eur J Nucl Med 1993, 20:260-263

Liu JS, Molchanova TP, Gu LH, Wilson JB, Hopmeier P, Schnedl W, Balaun E, Krejs GJ, Huisman THJ: Hb-Graz or a2b22(NA2)His-Leu; a new b chain variant observed in four families from southern Austria. Hemoglobin 1992, 16:493-501

Toplak H, Schnedl W, Weber K, Brunner G, Reisinger E: Diabetes mellitus und Infektionen. Folia Chemotherapeutica Austriaca, Antibiotikamonitor 1990, 7:12-13

Kooperationen

Division of Endocrinology, Metabolism, and Nutrition

Department of Medicine, Duke University Medical Center Durham NC, USA

Departments of Pathology & Anatomical Sciences and Child Health,
University of Missouri-Columbia

School of Medicine, Columbia, MO, USA

STYJOBS (STYrian Juvenile OBesity Study)

Projekte zur Erforschung von Risikoprofilen in der Frühphase von Übergewicht, Fettsucht und Atherosklerose, Medizinische Universität Graz

Institut für Nuklearmedizin

Wilhelminenspital, Wien

Diabetes Research Department and the Centre

for Molecular Genetics at the Peninsula Medical School and Royal Devon and Exeter Hospital, Exeter, UK

Institut fĂĽr Lebensmittelchemie

Technische Universität Dresden, Deutschland

Abteilung fĂĽr Nuklearmedizin

Universitätsklinik für Radiologie, Medizinische Universität Graz

Zentrum fĂĽr Molekulare Medizin

Institut für Pathophysiologie und Immunologie, Medizinische Universität Graz

Arkray Incorporated Laboratory Product Division

Kyoto, Japan

Department of Tropical Medicine and Infectious Diseases

University of Rostock Medical School, Rostock, Germany

Division of Endocrinology and Metabolism

Department of Internal Medicine III, University of Vienna

Zentrallabor

Krankenanstalt Rudolfstiftung, Wien

Centre of Behavioural and Health Sciences

University of Tartu, Tartu, Estonia